Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients Romeo BascioniFrancesca GiorgiEnrica Testa OriginalPaper Pages: 205 - 210
Bone marrow fibroblastic progenitors in patients with advanced breast cancer Norma A. ChasseingYolanda G. TrejoLia S. Rumi OriginalPaper Pages: 211 - 218
Predictors of response to second-line endocrine therapy for breast cancer K.L. CheungP.C. WillsherJ.F.R. Robertson OriginalPaper Pages: 219 - 224
Consistency of patient- and doctor-assessed cosmetic outcome after conservative treatment of breast cancer Holli KaijaSaaristo RauniHakama Matti OriginalPaper Pages: 225 - 228
Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture Farzaad Abdi-DezfuliLivar FrøylandRolf K. Berge OriginalPaper Pages: 229 - 239
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods A. MolinoR. MiccioloG.L. Cetto OriginalPaper Pages: 241 - 249
A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer Michael GershanovichAugust GarinEastern European Study Group OriginalPaper Pages: 251 - 262
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial Jan FrisellElisabet LidbrinkLars-Erik Rutqvist OriginalPaper Pages: 263 - 270